Arne Bartol

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Transcription Factor

Clinical Evaluation

Randomized Controlled Trial

Top Venues

Health economics review

Health economics, policy, and law

This page only lists publications with an associated author ORCID identifier.

Publications

Iris An der Heiden, Guido Schiffhorst, Laura Müller, Martin Albrecht, Arne Bartol, Stefanie Wiberny
Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany: a statistical model. Health economics review 14 (1) (2024)
Iris An der Heiden, Guido Schiffhorst, Laura Müller, Martin Albrecht, Arne Bartol, Stefanie Wiberny
Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany: a statistical model. Health economics review 14 (1) (2024)
Iris An der Heiden, Guido Schiffhorst, Laura Müller, Martin Albrecht, Arne Bartol, Stefanie Wiberny
Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany: a statistical model. Health economics review 14 (1) (2024)
Katrin Kleining, Jan Laufenberg, Philip Thrun, Dorothee Ehlert, Jürgen Wasem, Arne Bartol
Ten years of German benefit assessment: price analysis for drugs with unproven additional benefit. Health economics, policy, and law (2023)